Virolysis and in vitro neutralization of HIV-1 by humanized monoclonal antibody hNM-01

Hybridoma

Volumn 19, Issue 6, 2000, Pages 427-434

  Nakamura, M ^a   Terada, M ^b   Sasaki, H ^a   Kamada, M ^a   Ohno, T ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nissin Central Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G; LEUCINE; METHIONINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HNM 01; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIBODY COMBINING SITE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENTARITY DETERMINING REGION; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; VIRUS ENVELOPE; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTI-HIV AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; COMPLEMENT ACTIVATION; COMPLEMENTARITY DETERMINING REGIONS; HIV-1; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; MICE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; RABBITS; RECOMBINANT FUSION PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE; RNA VIRUSES;

EID: 0034537635     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/027245700750053913     Document Type: Article

References (30)

1. HIV entry and its inhibition
2. Vaccination of chimpanzees against HIV-1
3. Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees
4. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody
5. Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1
6. Summary of workshop on passive immunotherapy in the prevention and treatment of HIV infection
7. Passive immunotherapy I AIDS: A randomized trial of serial human immunodeficiency virus positive transfusion of plasma rich in p24 antibodies versus transfusions of seronegative plasma
8. Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: Results of a 12-months multicenter double-blind controlled trial
9. Principal neutralizing domain of human immunodeficiency virus type 1 envelope protein
10. Conserved sequence and structural elements in HIV-1 principal neutralization determinant
11. Differential ability of human immunodeficiency virus isolates to productivity infect human cells
12. Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity
13. Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1
14. A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120
15. Complement-dependent virolysis of HIV-1 with monoclonal antibody NM-01
16. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction
17. Transcription maps of polyoma-virus specific RNA: Analysis by two dimensional S1-gel mapping
18. Structure of human immunoglobulin γ genes: Implications for evaluation of a gene family
19. Cloned human and mouse κ immunoglobulin constant and J region genes conserve homology in functional segments
20. Amino acid sequence of the VH region of a human myeloma immunoglobulin (IgG New)
21. Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI
22. Canonical structures for the hypervariable regions of immunoglobulins
23. Inhibition of restriction endonuclease NciI cleavage by phosphothiorate groups and its application to oligonucleotide-directed mutagenesis
24. Characterization of the AIDS associated retroviruses reverse transcriptase and optical conditions for its detection in vitro
25. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
26. A simple method of estimating fifty percent endpoints
27. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins
28. Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cells
29. Passive immunoneutralization of human immunodeficiency virus in patients with advance AIDS